Skip to main content

Table 5 Adverse events of patients with TACE-Iodine 125 or TACE-RFA treatments after PSM

From: Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma

Adverse events Grade I and II Grade III and IV
TACE-RFA TACE-Iodine 125 P value TACE-RFA TACE-Iodine 125 P value
Fatigue 10 12 0.607 1 1 > 0.99
Nausea 8 8 > 0.99 0 1 > 0.99
Fever 3 7 0.172 0 0 > 0.99
Leucopenia 0 6 0.003 0 0 > 0.99
Liver pain 25 24 0.794 2 2 > 0.99
Hepatic hemorrhage 3 2 0.642 1 0 > 0.99
Increased ALT 6 14 0.034 3 6 0.280
Pneumothorax 2 4 0.389 0 0 > 0.99
  1. Abbreviations: TACE Transarterial chemoembolization; RFA Radiofrequency ablation;